Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 · New England Journal of Medicine · 4,031 citations
https://doi.org/10.1056/nejmoa2032183
M
Melanie J. Davies
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.6K
Papers
90.4K
Citations
132
h-index
774
i10-index
Melanie J. Davies is an academic researcher from University of Nottingham. The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Metabolism, Diabetes, and Cancer. The author has an h-index of 132, co-authored 1318 publications.
ORCID: 0000-0002-9987-9371Papers by this author
worksType 2 diabetes
2017 · The Lancet · 2,413 citations
https://doi.org/10.1016/s0140-6736(17)30058-2
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis
2012 · Diabetologia · 1,757 citations
https://doi.org/10.1007/s00125-012-2677-z
The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis
2006 · Diabetic Medicine · 1,284 citations
https://doi.org/10.1111/j.1464-5491.2006.01943.x
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
2023 · New England Journal of Medicine · 1,275 citations
https://doi.org/10.1056/nejmoa2306963
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
2021 · JAMA · 1,093 citations
https://doi.org/10.1001/jama.2021.3224
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat